What is the purpose of clinical trials in the context of GMOs?

The purpose of clinical trials in the context of genetically modified organisms (GMOs) is to evaluate safety and efficacy for human health and the environment. These trials are designed to assess how GMOs interact with human health and ecological systems, ensuring that any potential risks are identified and addressed before these products are introduced to the market or released for public consumption.

Safety evaluations focus on possible allergic reactions, toxic effects, and nutritional impacts of the GMO on human health. Environmental assessments examine how the modified traits may affect biodiversity, non-target organisms, and overall ecosystem health. By conducting these rigorous trials, regulatory bodies can ensure that GMOs are safe for both consumption and environmental release, protecting public health and environmental integrity.

This process is crucial because it helps build public trust in biotechnology and ensures compliance with regulatory standards. Ensuring safety and efficacy ultimately supports the responsible adoption of GMOs in agriculture, aiming for innovations that can benefit both society and the environment.